| # | Drug | Count |
|---|---|---|
| 0 | EFAVIRENZ | 14 |
| 1 | LAMIVUDINE | 13 |
| 2 | LAMIVUDINE ORAL | 13 |
| 3 | METHOTREXATE | 11 |
| 4 | METHOTREXATE SODIUM | 11 |
| 5 | RIFAMPICIN | 10 |
| 6 | ZIDOVUDINE | 10 |
| 7 | DAPSONE | 9 |
| 8 | DAPSONE GEL, 5% | 9 |
| 9 | DASPONE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFAVIRENZ | 14 | 0.0013 |
| 1 | CLOFAZIMINE | 8 | 0.0012 |
| 2 | RIFAMPICIN | 10 | 0.0010 |
| 3 | ZIDOVUDINE | 10 | 0.0010 |
| 4 | DASPONE | 9 | 0.0009 |
| 5 | DAPSONE GEL, 5% | 9 | 0.0009 |
| 6 | DAPSONE | 9 | 0.0008 |
| 7 | PYRAZINAMIDE | 7 | 0.0007 |
| 8 | ETHAMBUTOL HYDROCHLORIDE | 2 | 0.0007 |
| 9 | RIFABUTIN | 2 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sulfone [EPC] | 9 | 0.0008 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 19 | 0.0008 |
| 2 | Antimycobacterial [EPC] | 15 | 0.0006 |
| 3 | Rifamycin Antimycobacterial [EPC] | 2 | 0.0006 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 13 | 0.0003 |
| 5 | Rifamycin Antibacterial [EPC] | 6 | 0.0002 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 18 | 0.0002 |
| 7 | Nucleoside Analog Antiviral [EPC] | 5 | 0.0001 |
| 8 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 4 | 0.0000 |